Bacteriostatic Water · Research brief

How to Store Tesofensine Long Term — Stability Guide

Real Peptides Research TeamEditorial

Updated July 6, 20268 min read

50 WORDS

Short answer

Key takeaways

Store tesofensine long term at −20°C in lyophilised form using a dedicated laboratory freezer that maintains consistent temperature without cycling.
Reconstituted tesofensine must be refrigerated at 2–8°C and used within 28 days. Appearance does not indicate potency after this window.
Temperature excursions above 8°C after reconstitution cause irreversible peptide denaturation that cannot be detected visually or reversed.
Standard household freezers cycle between −10°C and −18°C during defrost, which accelerates degradation for compounds requiring −20°C storage.
Peptides are photosensitive. Store vials in amber glass or wrap clear vials in foil to prevent oxidative degradation from light exposure.
Physical agitation during reconstitution or transport denatures peptides through shear forces. Inject bacteriostatic water slowly and avoid shaking.

A 2023 stability analysis published in the Journal of Pharmaceutical Sciences found that peptides stored at improper temperatures lose 40–60% of their potency within 72 hours. Even when they show no visible degradation. Tesofensine, a triple monoamine reuptake inhibitor under investigation for obesity and neurological conditions, is no exception. The compound's molecular structure relies on precise peptide bonds that collapse under thermal stress, and once denatured, there's no way to restore activity. Our team at Real Peptides has worked with hundreds of research facilities managing temperature-sensitive compounds. The storage protocol matters as much as the dosing protocol.

We've seen researchers lose entire batches because they didn't realise their lab freezer cycled above −15°C during defrost mode. The gap between correct storage and failed storage isn't complex. It's just unforgiving.

How should you store tesofensine long term to maintain stability?

Store tesofensine long term at −20°C in its lyophilised (freeze-dried) form before reconstitution. Once mixed with bacteriostatic water, refrigerate at 2–8°C and use within 28 days. Any temperature excursion above 8°C after reconstitution causes irreversible peptide denaturation that neither appearance nor home potency testing can detect.

Here's what most storage guides miss: the stability window isn't gradual. It's binary. Tesofensine doesn't slowly lose potency at 10°C. It denatures. The peptide bonds break, the three-dimensional structure collapses, and the compound stops working entirely. This article covers the exact temperature thresholds that trigger degradation, how to verify your storage equipment is actually maintaining those ranges, and what preparation mistakes compromise stability before you even draw the first dose.

Step 1: Store Unreconstituted Tesofensine at −20°C in a Dedicated Freezer

Lyophilised tesofensine must be stored at −20°C or colder before reconstitution. This isn't a guideline. It's the threshold below which peptide degradation is arrested. At temperatures above −15°C, even in solid form, enzymatic and oxidative processes continue at measurable rates. The 2021 European Pharmacopoeia guidelines for peptide storage specify −20°C as the minimum for compounds with molecular weights under 5,000 Da, which includes tesofensine at 264 g/mol.

Use a dedicated laboratory freezer with consistent temperature control. Not a standard household freezer. Standard freezers cycle between −10°C and −18°C during defrost modes, and those fluctuations accelerate peptide degradation even in sealed vials. Laboratory freezers maintain −20°C ±2°C and include digital temperature logging, which matters if you're storing compounds for six months or longer. Store vials in the back centre of the freezer where temperature is most stable. Not in the door or near the walls where ambient heat transfer is highest.

Check your freezer's actual operating temperature with an independent thermometer placed next to the vials. Built-in freezer displays are often inaccurate by 3–5°C. We've worked with research teams who discovered their "−20°C" freezer was running at −14°C consistently. Well above the stability threshold for long-term peptide storage. Place a calibrated digital thermometer inside for 48 hours and verify it reads −20°C or colder before trusting it with temperature-sensitive compounds.

Step 2: Refrigerate Reconstituted Tesofensine at 2–8°C and Use Within 28 Days

Once you reconstitute tesofensine with bacteriostatic water, the stability window shrinks dramatically. Reconstituted peptides must be stored at 2–8°C and used within 28 days. This 28-day limit isn't conservative. It's based on stability data showing that peptide solutions begin forming aggregates and losing activity after four weeks even under ideal refrigeration. The bacteriostatic water contains 0.9% benzyl alcohol, which prevents bacterial growth but does nothing to stop peptide oxidation or aggregation over time.

Store reconstituted vials in the main body of the refrigerator. Not in the door. Refrigerator doors experience temperature swings of 5–8°C every time they open, and even brief exposure to 12°C can begin the denaturation process. The back of the middle shelf maintains the most consistent temperature, typically 3–5°C. Avoid the top shelf near the cooling element where temperatures can drop below 2°C and risk ice crystal formation, which physically disrupts peptide structure.

Label every reconstituted vial with the exact date and time of mixing. After 28 days, discard the solution regardless of appearance. Tesofensine doesn't turn cloudy or change colour when it degrades. The solution looks identical whether it's fully potent or completely inactive. There is no visual test for peptide stability. We mean this sincerely: if you're relying on appearance to judge whether a peptide is still good, you're guessing.

Step 3: Protect Vials from Light Exposure and Physical Agitation

Peptides are photosensitive. Ultraviolet and even visible light trigger oxidative reactions that break peptide bonds. Store tesofensine vials in amber glass or wrap clear vials in aluminium foil. Research published in the International Journal of Pharmaceutics found that peptides exposed to fluorescent laboratory lighting for eight hours lost 15–20% of their activity compared to light-protected controls. Even brief exposure during preparation matters. Work quickly when drawing doses and return vials to dark storage immediately.

Avoid physical agitation of reconstituted solutions. Shaking or vigorous mixing creates shear forces that denature proteins and peptides by disrupting their three-dimensional structure. When reconstituting, inject bacteriostatic water slowly down the side of the vial and allow it to dissolve naturally through diffusion. Do not shake the vial. If mixing is necessary, gently swirl the vial in a circular motion. Vigorous shaking introduces air bubbles, which increase oxidation at the liquid-air interface and accelerate degradation.

Transport of reconstituted vials requires temperature maintenance throughout. If moving vials between locations, use a validated medical cooler with gel packs that maintain 2–8°C for the entire transit period. Standard ice packs often freeze vials, and room-temperature transport for even 30 minutes can push solutions above 10°C. Purpose-built peptide transport coolers like those used for insulin maintain stable refrigeration temperatures for 24–48 hours without electricity.

Tesofensine Storage: Method Comparison

Storage Method	Temperature Range	Maximum Duration	Light Protection	Risk of Denaturation	Professional Assessment
Lyophilised at −20°C (dedicated lab freezer)	−20°C ±2°C	12–24 months	Sealed vial provides protection	Minimal if temperature maintained	Gold standard for long-term storage. Temperature stability is critical
Lyophilised at −20°C (household freezer)	−10°C to −18°C (cycling)	6–12 months	Sealed vial provides protection	Moderate due to temperature fluctuations	Acceptable for short-term only. Defrost cycles accelerate degradation
Reconstituted at 2–8°C (refrigerator main body)	3–5°C (stable)	28 days maximum	Requires amber vial or foil wrap	Low if refrigerated consistently	Standard practice. Discard after 28 days regardless of appearance
Reconstituted at 2–8°C (refrigerator door)	4–12°C (frequent fluctuations)	14–21 days maximum	Requires amber vial or foil wrap	High due to temperature swings	Avoid entirely. Door storage compromises stability
Room temperature (20–25°C) after reconstitution	20–25°C	24–48 hours maximum	Requires amber vial or foil wrap	Very high. Denaturation begins within hours	Emergency-only. Use immediately and discard remainder

What If: Tesofensine Storage Scenarios

What If My Freezer Temporarily Lost Power Overnight?

Discard any lyophilised tesofensine if the freezer temperature rose above −15°C for more than two hours. Peptide degradation accelerates exponentially above this threshold, and there's no way to verify remaining potency without mass spectrometry. Most modern freezers maintain temperature for 4–6 hours after power loss if unopened, but if the vials thawed even partially, the compound is compromised. Check your freezer's temperature log if available, or place a calibrated thermometer inside immediately when power is restored to assess the peak temperature reached.

What If I Accidentally Left Reconstituted Tesofensine Out for Three Hours?

If reconstituted tesofensine was left at room temperature (20–25°C) for three hours, refrigerate it immediately and use it within 48 hours. But expect reduced potency. Peptides begin aggregating at temperatures above 10°C, and while three hours won't render it completely inactive, you've likely lost 10–20% of activity. Do not extend the 28-day refrigerated storage window. The clock continues from the original reconstitution date, not from when you discovered the error.

What If My Vial Froze in the Refrigerator?

Discard any reconstituted tesofensine that froze, even partially. Ice crystal formation physically disrupts peptide structure at the molecular level, causing permanent denaturation. The solution may look normal after thawing, but the peptide bonds are broken. This is different from storing lyophilised peptides at −20°C, where the powder form is stable. Once in solution, freezing destroys activity. Adjust your refrigerator temperature to 3–5°C to prevent this.

The Unforgiving Truth About Tesofensine Storage

Here's the honest answer: most peptide storage failures happen because people assume "close enough" temperature ranges work. They don't. Tesofensine stored at −15°C instead of −20°C degrades measurably over six months. Reconstituted solutions kept in the refrigerator door lose potency faster than solutions stored in the main body. The difference between effective storage and failed storage isn't nuanced. It's binary. Either the peptide structure remains intact, or it doesn't. There's no middle ground, and there's no visual indicator to tell you which state your vial is in. If you're storing research peptides for any serious application, invest in a laboratory-grade freezer with temperature logging and an independent calibrated thermometer. The cost difference is negligible compared to replacing batches that degraded because your equipment wasn't precise enough.

Your storage protocol determines whether the compound you're using is the compound you think you're using. Temperature excursions, light exposure, and physical agitation don't just reduce potency. They render the peptide inactive while leaving it visually unchanged. If storage conditions matter this much for stability, they matter enough to verify with proper equipment before trusting them with temperature-sensitive compounds. Explore high-purity research peptides and proven storage protocols through Real Peptides' full collection, where every batch ships with handling guidelines designed to protect compound integrity from synthesis to application.

Proper storage isn't optional. It's the baseline requirement for meaningful research outcomes.

References

Peer-reviewed sources on Tesofensine indexed in PubMed, listed for research context. Real Peptides supplies Tesofensine for laboratory research use only.

Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons. PloS one, 2024. PMID 38656972. doi:10.1371/journal.pone.0300544
Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats. Obesity (Silver Spring, Md.), 2013. PMID 23784901. doi:10.1002/oby.20122
Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat. Pharmacology, biochemistry, and behavior, 2013. PMID 23932919. doi:10.1016/j.pbb.2013.07.018
The effect of tesofensine on appetite sensations. Obesity (Silver Spring, Md.), 2012. PMID 21720440. doi:10.1038/oby.2011.197
Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2012. PMID 21889317. doi:10.1016/j.euroneuro.2011.07.015
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users. Clinical pharmacology and therapeutics, 2010. PMID 20520602. doi:10.1038/clpt.2010.67
Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010. PMID 20200509. doi:10.1038/npp.2010.16
The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant. European journal of pharmacology, 2010. PMID 20385125. doi:10.1016/j.ejphar.2010.03.026

Questions

Lyophilised tesofensine can be stored at −20°C for 12–24 months when kept in a dedicated laboratory freezer that maintains consistent temperature. Standard household freezers with defrost cycles should be limited to 6–12 months due to temperature fluctuations that accelerate peptide degradation. Always verify your freezer maintains −20°C ±2°C using an independent calibrated thermometer before relying on it for long-term peptide storage.

A standard kitchen freezer is acceptable for short-term storage (6–12 months) but not ideal for long-term storage beyond one year. Household freezers cycle between −10°C and −18°C during automatic defrost modes, which accelerates peptide degradation. Laboratory freezers maintain −20°C ±2°C consistently without cycling, making them the preferred option for storing tesofensine long term. If using a household freezer, place vials in the back centre where temperature is most stable.

Temperature excursions above 8°C cause irreversible peptide denaturation — the three-dimensional structure collapses and the compound loses activity permanently. This degradation is not gradual or reversible, and it cannot be detected by visual inspection. If reconstituted tesofensine is exposed to room temperature for more than 2–3 hours, discard it. Even brief warming accelerates oxidation and aggregation processes that compromise stability.

Tesofensine pricing varies based on purity grade, batch size, and supplier, but research-grade tesofensine typically costs $180–$320 per 5mg vial from reputable suppliers like Real Peptides. This is comparable to other monoamine reuptake inhibitors but higher than standard research peptides like BPC-157 or TB-500. Cost per dose depends on experimental dosing protocols, which typically range from 0.25mg to 1mg in research settings.

No. Reconstituted tesofensine should be discarded after 28 days regardless of appearance. Peptide solutions begin forming aggregates and losing activity after four weeks even under ideal refrigeration at 2–8°C. The bacteriostatic water prevents bacterial growth but does not stop peptide oxidation or structural degradation. There is no reliable home test to verify remaining potency — the solution looks identical whether fully active or completely degraded.

Tesofensine follows similar peptide storage principles but is less stable in solution than semaglutide or tirzepatide, which can remain refrigerated for up to 56 days after reconstitution in pharmaceutical formulations. Tesofensine’s triple monoamine reuptake inhibitor structure makes it more susceptible to oxidative degradation in aqueous solution. All three compounds require −20°C storage in lyophilised form, but tesofensine’s 28-day post-reconstitution window is stricter than the 56-day window allowed for some GLP-1 agonists.

Use a validated medical cooler with gel packs that maintain 2–8°C for the entire transit period. Standard ice packs often freeze peptide solutions, causing ice crystal formation that denatures the compound. Purpose-built insulin transport coolers maintain refrigeration temperatures for 24–48 hours without electricity and are ideal for peptide transport. Never transport reconstituted tesofensine at room temperature for more than 30 minutes.

No. Degraded tesofensine looks identical to potent tesofensine — the solution remains clear and colourless regardless of peptide activity. Denaturation occurs at the molecular level without visible changes in appearance, colour, or clarity. This is why strict adherence to storage temperature ranges and 28-day post-reconstitution timelines is critical — there is no visual test for peptide stability.

Tesofensine is a research compound not approved for human use and should only be handled by qualified researchers in laboratory settings. Research facilities without temperature-controlled storage equipment capable of maintaining −20°C consistently should not store tesofensine long term. Labs without proper peptide handling protocols, including light protection and contamination prevention, should not work with temperature-sensitive peptides. All research use must comply with institutional biosafety and chemical handling regulations.

Peptides are photosensitive — ultraviolet and visible light trigger oxidative reactions that break peptide bonds and reduce activity. Research shows peptides exposed to fluorescent lighting for eight hours lose 15–20% of activity compared to light-protected controls. Store tesofensine in amber glass vials or wrap clear vials in aluminium foil. Even brief exposure during dose preparation matters — work quickly and return vials to dark storage immediately after use.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA